Page 231 - Environmental Nanotechnology Applications and Impacts of Nanomaterials
P. 231

216   Principles and Methods

         TABLE 6.4 In vitro Systems Defined by Portal of Entry/Potential Target Organs
         Portal of Entry/Organs  Cell/Tissue Type  Cellular Response/Pathology

         Lung               Epithelium            Toxicity, inflammation,
                                                  translocation, carcinogenesis
                            Macrophages           Toxicity, chemotaxis,
                                                  phagocytosis, inflammation
         Skin               Keratinocytes         Cytotoxicity, inflammation
         Mucosa             Buccal/intestinal     Cytotoxicity, inflammation,
                             epithelium           translocation
         Cardiovascular system  Endothelial cells   Cytotoxicity, homeostasis,
                             (e.g.,  HUVEC)       translocation
         Blood              Red blood cells, platelets,  Inflammation/immune
                             bone marrow          response
                             (megakaryocytes)
         Liver              Hepatocytes           Toxicity
                            Kupffer cells         Inflammation, coagulation
         Spleen             Lymphocytes           Immune response
         Central and peripheral   Neuronal cells  Toxicity, inflammation,
         nervous system                           translocation
                            Astroglial, microglial cells  Inflammation
         Heart              Cardiomyocytes        Toxicity, inflammation,
                                                  function
         Kidney             Cell (e.g., HK-2, MDCK,  Toxicity, inflammation,
                             LCC-PK1)             translocation
          Adapted from [12].


        spread as a powder or a dust, it would be more appropriate to test its
        effects in bronchial and alveolar epithelial cells and/or pulmonary alve-
        olar macrophages. Thus, the closer the test scenario is to the real-life
        exposure conditions, the better the predictive value of the test. The pre-
        dictive value is further enhanced by using a test strategy that reflects
        a mechanism of injury, in particular, if that mechanism also leads to
        in vivo pathology. Since the hierarchical oxidative stress paradigm has
        proven useful to understand the generation of lung and cardiovascular
        injury by ambient ultrafine particles, we will briefly discuss this
        approach for in vitro NM testing.
          As an initial step, we recommend rapid screening procedures such as
        the MTT and LDH assays. The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
        diphenyltetrazolium bromide] assay, also known as the MTT cellular
        proliferation assay, is based on the ability of dehydrogenase enzymes in
        viable cells to cleave the tetrazolium rings of pale yellow MTT to form
        dark blue formazan crystals that are impermeable to the surface mem-
        brane of viable cells [47]. This oxidation takes place in cells with active
        reductases and therefore reflects cell viability. The lactate dehydroge-
        nase (LDH) assay measures LDH release after damage to the surface
        membrane. This colorimetric assay is dependent on the ability of this
   226   227   228   229   230   231   232   233   234   235   236